These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

210 related articles for article (PubMed ID: 408116)

  • 1. [Oral iron treatment: intestinal absorption and the influence of a meal (author's transl)].
    Werner E; Kaltwasser JP; Ihm P
    Dtsch Med Wochenschr; 1977 Jul; 102(29):1061-4. PubMed ID: 408116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Intestinal absorption from therapeutic iron doses (author's transl)].
    Werner E; Kaltwasser JP; Ihm P
    Arzneimittelforschung; 1976; 26(11):2093-100. PubMed ID: 1037255
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Iron absorption after oral application of a combination of Fe2+-succinate and multivitamins (author's transl)].
    Zillessen E; Frerichs F; Herzfeld U; Bader R; Hunstein W
    Arzneimittelforschung; 1977; 27(8):1606-8. PubMed ID: 578755
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Serum ferritin as a control parameter for oral iron therapy (author's transl)].
    Kaltwasser JP; Werner E; Becker H
    Dtsch Med Wochenschr; 1977 Aug; 102(32):1150-5. PubMed ID: 891409
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of so-called iron absorption-promoting additives in humans as measured with the 59 Fe-absorption whole-body retention test. Intraindividual comparison of succinate, dioctylsulfosuccinate-, fumarate-, aspartate-, ascorbate- and folate-effects on 59 Fe-absorption from therapeutic 59 Fe 2+ -doses in persons with normal and depleted iron stores.
    Heinrich HC; Bartels H; Gabbe EE; Kugler G; Oppitz KH
    Arzneimittelforschung; 1972 Jul; 22(7):1091-103. PubMed ID: 4628442
    [No Abstract]   [Full Text] [Related]  

  • 6. Posthaemorrhagic iron deficiency. Clinical course, 59Fe whole-body iron losses, and oral iron supplementation.
    Hausmann K; Kuse R; Meinecke KH; Bartels H; Gabbe EE; Heinrich HC
    Arzneimittelforschung; 1976; 26(10):1884-91. PubMed ID: 1037208
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Iron metabolism, iron deficiency and iron therapy (author's transl)].
    Stötter G
    MMW Munch Med Wochenschr; 1974 Nov; 116(47):2091-98. PubMed ID: 4216817
    [No Abstract]   [Full Text] [Related]  

  • 8. [Iron absorption from slow releasing iron tablet].
    Saito H
    Rinsho Ketsueki; 1972 Oct; 13(5):827-30. PubMed ID: 4630201
    [No Abstract]   [Full Text] [Related]  

  • 9. Oral iron with succinic acid in the treatment of iron deficiency anaemia. An evaluation based on measurements of iron absorption using a whole body counter and a double radioiron technique.
    Hallberg L; Norrby A; Sölvell L
    Scand J Haematol; 1971; 8(2):104-11. PubMed ID: 4999378
    [No Abstract]   [Full Text] [Related]  

  • 10. Deficiency and absorption of iron in man.
    Höglund S
    Acta Med Scand Suppl; 1970; 518():1-24. PubMed ID: 4996391
    [No Abstract]   [Full Text] [Related]  

  • 11. Bioavailability of trivalent iron in oral iron preparations. Therapeutic efficacy and iron absorption from simple ferric compounds and high- or low-molecular weight ferric hydroxide-carbohydrate complexes.
    Heinrich HC
    Arzneimittelforschung; 1975 Mar; 25(3):420-6. PubMed ID: 1174047
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ascorbic acid effect on intestinal iron absorption in different types of anaemias.
    El-Hawary MF; El-Shobaki FA; Kholeif T; Sakr R; El-Bassousy EM; Abdel-Khalek K; Khashaba A
    Gaz Egypt Paediatr Assoc; 1975 Apr; 23(2):145-9. PubMed ID: 816695
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intestinal iron absorption under the influence of available storage iron and erythroblastic hyperplasia. Comparative studies in children with hereditary spherocytosis, nonspherocytic enzymopenic hemolytic anemia, acquired hemolytic anemia, vitamin B12 deficiency induced megaloblastic anemia, erythroblastic hypoplasia and aplastic anemia.
    Bender-Götze C; Heinrich HC; Gabbe EE; Oppitz KH; Schröter W; Whang DH; Schäfer KH
    Z Kinderheilkd; 1975; 118(4):283-301. PubMed ID: 1130121
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Iron absorption in different types of diet in Mexico].
    Maisterrena JA; Murphy CA; Tovar-Zamora E
    Gac Med Mex; 1973 Aug; 106(2):131-9. PubMed ID: 4754818
    [No Abstract]   [Full Text] [Related]  

  • 15. [Quantitative measurement of 59Fe-absorption. Comparison between iron labelled Parkevit-Fe and an iron-mono-preparation using a wholebody counter (author's transl)].
    Bräuer H
    MMW Munch Med Wochenschr; 1981 Jan; 123(5):181-3. PubMed ID: 6780894
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bioavailability and therapeutic efficacy of bivalent and trivalent iron preparations.
    Kaltwasser JP; Werner E; Niechzial M
    Arzneimittelforschung; 1987 Jan; 37(1A):122-9. PubMed ID: 3566867
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Therapy of iron deficiency].
    Heilmann E
    Dtsch Med Wochenschr; 1979 Sep; 104(39):1364-6. PubMed ID: 477564
    [No Abstract]   [Full Text] [Related]  

  • 18. [Optimal oral dosage in iron compensation therapy in nonbleeding patients with normal wholebody-59 Fe-elimination rate].
    Heinrich HC
    Med Klin; 1973 Jul; 68(30):981-5. PubMed ID: 4725494
    [No Abstract]   [Full Text] [Related]  

  • 19. Iron absorption from maize. Effect of ascorbic acid on iron absorption from maize supplemented with ferrous sulphate.
    Björn-Rasmussen E; Hallberg L
    Nutr Metab; 1974; 16(2):94-100. PubMed ID: 4209332
    [No Abstract]   [Full Text] [Related]  

  • 20. [Treatment of sideropenic anemia by means of a preparation that gradually releases iron into the intestine].
    Piancino G; Brusa L; Padula F
    Minerva Med; 1972 Nov; 63(81):4422-7. PubMed ID: 4565685
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.